SGHT PEER ANALYSIS

Sight Sciences Inc — metric-by-metric comparison with peers and the industry median

SGHTSight Sciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

SGHTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SGHT	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
P/E	—	20.55●	120.21	612.13	—	—	26.49
P/B	5.35	2.48	13.12	1.11	-71.55●	1.34	2.48
EV/EBITDA	—	9.87●	25.01	11.25	—	35.20	14.85
P/S	3.63	2.08	7.52	1.21●	234.58	2.99	2.56

Financial Health
Metric	SGHT	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Current Ratio	5.86	2.57	2.25	3.58	6.57●	2.31	3.28
Debt/Equity	77.5%	62.9%	35.0%	1.0%	-22.6%●	28.1%	44.7%
NetDebt/EBITDA	1.36	1.72	0.42	-1.64●	0.71	4.71	0.82

Profitability
Metric	SGHT	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Net Margin	-46.8%	10.1%●	6.3%	0.2%	-3,684.6%	-45.0%	-5.7%
ROE	-56.6%	12.1%	12.9%●	0.2%	—	-21.0%	-8.6%
ROA	-31.1%	6.1%	8.0%●	0.2%	-264.3%	-15.7%	-6.4%
EBITDA Margin	-39.8%	25.6%	30.6%●	9.4%	-818.8%	9.8%	5.2%

Growth + Dividend
Metric	SGHT	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Rev. Growth	1.8%	—	39.1%●	6.5%	-26.0%	11.7%	7.4%
NI Growth	—	—	—	-62.9%	—	—	16.7%
Div. Yield	—	3.5%●	0.0%	1.1%	—	0.0%	1.1%
Payout	—	52.8%	0.0%	656.3%	—	0.0%	39.0%

Valuation
Metric	SGHT	TMCI	MASS	RXST	OFIX	INFU	Ind. Median
P/E	—	—	—	—	—	25.62	26.49
P/B	5.35	3.58	2.16	0.83●	1.07	3.45	2.48
EV/EBITDA	—	—	—	—	6.15●	8.64	14.85
P/S	3.63	1.33	5.02	1.73	0.57●	1.42	2.56

Financial Health
Metric	SGHT	TMCI	MASS	RXST	OFIX	INFU	Ind. Median
Current Ratio	5.86	3.58	3.58	10.20●	2.87	2.14	3.28
Debt/Equity	77.5%	17.6%	3.3%●	4.1%	53.9%	38.8%	44.7%
NetDebt/EBITDA	1.36	0.83	4.04	4.79	1.21	0.80●	0.82

Profitability
Metric	SGHT	TMCI	MASS	RXST	OFIX	INFU	Ind. Median
Net Margin	-46.8%	-29.4%	-62.1%	-36.6%	-7.3%	5.6%●	-5.7%
ROE	-56.6%	-66.9%	-24.5%	-17.1%	-13.4%	13.9%●	-8.6%
ROA	-31.1%	-31.3%	-18.8%	-15.1%	-7.0%	7.8%●	-6.4%
EBITDA Margin	-39.8%	-22.3%	-46.0%	-33.9%	11.5%	18.2%●	5.2%

Growth + Dividend
Metric	SGHT	TMCI	MASS	RXST	OFIX	INFU	Ind. Median
Rev. Growth	1.8%	-1.7%	2.2%	-19.5%	2.6%	3.5%●	7.4%
NI Growth	—	—	—	—	—	148.0%	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SGHT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.